Social media support for young adults with leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This study tests a social media-based program to help young people with ALL remember to take their 6-MP medication during maintenance treatment. It aims to improve medication adherence through peer support and reminders.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 25 years old.
- You have been diagnosed with acute lymphoblastic leukemia (ALL), a type of blood cancer.
- You are taking the chemotherapy drug 6-MP (6-mercaptopurine) and have at least 6 months left on your maintenance treatment.
- You have an active social media account (like Instagram or TikTok) or are willing to download a platform for the study.
- You have missed a dose of 6-MP in the past month or have had at least one difficulty sticking to your treatment (such as forgetting or other barriers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help teenagers and young adults take their oral cancer medications as prescribed. It aims to make medication routines easier and improve adherence.
This trial tests a cell phone program to help teens manage their daily medications. It aims to make sticking to a medication routine easier for young people with long-term health conditions.
This study tests a special cell phone support program to help teenagers and young adults remember to take their daily medications. It aims to make it easier to stay on track with treatment for chronic health conditions.
This trial tests a mobile (phone) health program to help adolescents and young adults with leukemia take their oral chemotherapy medicine consistently. It may help if staying on daily pills is hard during the maintenance phase of treatment.
This study tests whether text message reminders can help patients stick to their daily oral chemotherapy schedule during the maintenance phase of ALL treatment. Participants receive friendly text reminders and can ask questions, aiming to make managing treatment easier.
This study tests a support program that helps parents give their child's daily leukemia medicine (6-MP) on schedule and overcome any barriers. It aims to make it easier for families to stick with treatment.
Hear when a new Acute Lymphobkastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.